FDA com­mis­sion­er an­nounces new role for Janet Wood­cock, down­shift­ing away from drugs

New FDA com­mis­sion­er Rob Califf told staff in a memo yes­ter­day evening that long­time drug cen­ter di­rec­tor Janet Wood­cock, who’s now serv­ing as Califf’s prin­ci­pal deputy, would take on more of a role as “a strate­gic thought part­ner, with de­ci­sion-mak­ing au­thor­i­ties” at sev­er­al dif­fer­ent of­fices with­in FDA. Cu­ri­ous­ly, the list of of­fices and cen­ters does not in­clude the Of­fice of New Drugs or the Of­fice of Gener­ic Drugs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER